Literature DB >> 18854781

Effects of intravitreal morphine administered at different time points after reperfusion in a rabbit model of ischemic retinopathy.

Mohammad Riazi-Esfahani1, Saman Kiumehr, Fahimeh Asadi-Amoli, Ahmad R Dehpour.   

Abstract

PURPOSE: To investigate the effects of morphine administered after reperfusion in a rabbit model of ischemic retinopathy.
METHODS: The right eyes of 54 albino New Zealand rabbits were randomly allocated into nine treatment groups (n = 6 in each group). The eyes in saline-control group received 0.1 mL of phosphate-buffered saline solution intravitreally. In the ischemia-saline group, ischemia was induced by raising the intraocular pressure to 150 mmHg for 60 minutes. Then 0.1 mL of phosphate-buffered saline solution was administered intravitreally 5 minutes after reperfusion. The eyes in three ischemia-morphine groups (ischemia-morphine 0 hour, 1 hour, and 18 hours) received 0.1 mL of morphine (10 micromol/L) intravitreally 5 minutes, 1 hour, or 18 hours after termination of 60 minutes of ischemia, respectively. The eyes in ischemia-naloxone-morphine group received 0.05 mL of naloxone (10 micromol/L) intravitreally followed by injection of 0.05 mL morphine (10 micromol/L) 5 minutes after termination of ischemia. Toxicity controls were performed with morphine (10 micromol/L) and naloxone (10 micromol/L) without ischemia. Histologic evaluation was performed for all groups on the seventh postoperative day.
RESULTS: Sixty minutes of ischemia led to severe cell loss in ganglion cell layer and thinning of the inner nuclear layer in ischemia-saline group compared with that of the saline-control group (P < 0.001). Thickness of the inner plexiform layer to the inner limiting membrane (a measure of inner retinal thickness) was significantly increased due to edema (P < 0.001). Administration of morphine 5 minutes after reperfusion significantly improved all of the above mentioned indices compared with ischemia-saline group (P < 0.001). Administration of morphine 1 hour after reperfusion had also a significant effect on the improvement of above mentioned indices compared with saline-control group (P < 0.05). However, the number of ganglion cells was significantly higher in ischemia-morphine 0 hour group compared with ischemia-morphine 1 hour group (P < 0.001). Morphine treatment 18 hours after reperfusion did not change the amount of injury. Administration of naloxone 5 minutes before morphine abolished most of the morphine protective effects.
CONCLUSION: Intravitreal administration of morphine immediately after reperfusion maximally protects retina against ischemia-reperfusion injury. Pharmacologic evidence suggests that this protective phenomenon may be mediated in part by opioid receptors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18854781     DOI: 10.1097/IAE.0b013e31818a211d

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  8 in total

1.  Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model.

Authors:  Shahid Husain; Yasir Abdul; Craig E Crosson
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-28       Impact factor: 4.799

2.  Dopaminergic amacrine cells express opioid receptors in the mouse retina.

Authors:  Shannon K Gallagher; Julia N Anglen; Justin M Mower; Jozsef Vigh
Journal:  Vis Neurosci       Date:  2012-05       Impact factor: 3.241

3.  Opioid receptor activation: suppression of ischemia/reperfusion-induced production of TNF-α in the retina.

Authors:  Shahid Husain; Gregory I Liou; Craig E Crosson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-20       Impact factor: 4.799

4.  Morphine Accumulates in the Retina Following Chronic Systemic Administration.

Authors:  Nikolas Bergum; Casey-Tyler Berezin; Gregory Dooley; Jozsef Vigh
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-25

Review 5.  Novel neuroprotective strategies in ischemic retinal lesions.

Authors:  Krisztina Szabadfi; Laszlo Mester; Dora Reglodi; Peter Kiss; Norbert Babai; Boglarka Racz; Krisztina Kovacs; Aliz Szabo; Andrea Tamas; Robert Gabriel; Tamas Atlasz
Journal:  Int J Mol Sci       Date:  2010-02-03       Impact factor: 6.208

6.  Protective effects of bestatin in the retina of streptozotocin-induced diabetic mice.

Authors:  Ahamed Hossain; David Heron; Ian Davenport; Thomas Huckaba; Richard Graves; Tarun Mandal; Syed Muniruzzaman; Shusheng Wang; Partha S Bhattacharjee
Journal:  Exp Eye Res       Date:  2016-06-23       Impact factor: 3.467

7.  Cirrhosis-induced morphological changes in the retina: possible role of endogenous opioid.

Authors:  Mohammad Abdullah Algazo; Saeed Amiri-Ghashlaghi; Bahram Delfan; Gholamreza Hassanzadeh; Fatemeh Sabbagh-Ziarani; Farahnaz Jazaeri; Ahmad Reza Dehpour
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

8.  The Neuropeptide Systems and their Potential Role in the Treatment of Mammalian Retinal Ischemia: A Developing Story.

Authors:  D Cervia; G Casini
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.